Clinical trial AB11002
AB11002 A prospective, multicenter, randomized, open-label, active-controlled, 2-parallel group, phase III study to compare efficacy and safety of masitinib to sunitinib in patients with gastrointestinla stromal tumor after progression with imatinib.
Cancers | |
---|---|
Organ | Stomach - Duodenum-esogastric junction |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 3 |
Academic trial | Non |
Sponsor | AB Science |
EudraCT Identifier | 2011-00179-041 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT01694277 |
Inclusion criteria | c-Kit positive. Progression under imatinib |
Last update |